GH Optimization Stack

intermediateEst. $100–$250/mo12-16 weeks2 compounds
Written by dr-sarah-chen|Updated 2026-04-01|6 min read

A growth hormone optimization protocol combining CJC-1295 and Ipamorelin for enhanced recovery, body composition, sleep quality, and anti-aging benefits without exogenous HGH.

CompoundDoseFrequencyTimingRole
CJC-1295 (no DAC / Mod GRF 1-29)100-200mcg1-2x daily (subcutaneous)Before bed (primary) and optionally morning fastedGHRH analog that stimulates pituitary GH release with extended half-life
Ipamorelin100-200mcg1-2x daily (subcutaneous)Before bed (primary) and optionally morning fastedSelective GHRP that triggers pulsatile GH release without cortisol or prolactin elevation

Why CJC-1295 + Ipamorelin

This is the most popular and well-studied growth hormone secretagogue combination. The two peptides work synergistically through different mechanisms:

CJC-1295 (no DAC), also known as Modified GRF 1-29, is a growth hormone-releasing hormone (GHRH) analog. It tells the pituitary gland to produce and release GH. However, GHRH alone can only release GH when the pituitary is "ready" — it works with the body's natural pulsatile rhythm rather than forcing release.

Ipamorelin is a growth hormone-releasing peptide (GHRP) that mimics ghrelin and activates the GHS receptor on the pituitary. It primes the pituitary to release GH. Unlike other GHRPs (GHRP-6, GHRP-2, Hexarelin), Ipamorelin does not significantly raise cortisol, prolactin, or appetite — making it the cleanest GHRP available.

When combined, CJC-1295 amplifies the GH pulse that Ipamorelin triggers. Studies show the combination produces 2-3x more GH release than either peptide alone.

Who This Protocol Is For

  • Adults over 30 experiencing age-related GH decline
  • Athletes and fitness enthusiasts seeking improved recovery and body composition
  • Anyone wanting better sleep quality (GH is intimately linked to deep sleep)
  • Those seeking anti-aging benefits of GH without the risks and cost of exogenous HGH
  • Individuals looking to improve skin quality, hair thickness, and overall vitality

CJC-1295: With DAC vs. Without DAC

This protocol uses CJC-1295 without DAC (also labeled as Mod GRF 1-29). Here is why:

FeatureCJC-1295 no DACCJC-1295 with DAC
Half-life~30 minutes~8 days
GH release patternPulsatile (natural)Sustained elevation
Dosing frequency1-2x daily2-3x weekly
Side effectsMinimalMore water retention, potential blunting
CostLowerHigher

The no-DAC version is preferred because it mimics natural GH physiology — pulsatile release rather than sustained elevation. This preserves pituitary sensitivity and reduces side effects.

Timing Is Everything

GH secretagogue effectiveness is highly dependent on timing:

  • Fasted state is mandatory: Insulin and carbohydrates blunt GH release by up to 80%. Do not eat for 2 hours before injection and 30 minutes after.
  • Before bed is optimal: The largest natural GH pulse occurs during the first 90 minutes of deep sleep. Injecting 15-30 minutes before bed amplifies this pulse.
  • Morning fasted dose: The secondary natural GH pulse occurs upon waking. A morning dose while fasted capitalizes on this window.
  • Avoid post-workout: Despite popular belief, the post-workout GH spike is minimal and short-lived. Fasted timing is far more impactful.

What to Expect: GH Optimization Results

Sleep and Recovery (Weeks 1-4)

The first benefit most users notice is dramatically improved sleep quality. Deeper sleep, more vivid dreams, and waking feeling more refreshed. Recovery from training improves noticeably — less DOMS, faster between sessions.

Body Composition (Weeks 4-8)

Gradual improvement in body composition: increased fat metabolism (especially visceral fat), improved skin quality, and the beginning of lean mass gains. Many users describe looking "tighter" and more defined without changes in diet.

Full Benefits (Weeks 8-16)

Peak benefits manifest: significant improvements in skin elasticity and thickness, faster hair and nail growth, improved joint comfort, enhanced exercise capacity, and measurable changes in body composition. IGF-1 levels typically increase 30-60% from baseline.

Monitoring and Bloodwork

Run the following at baseline, 8 weeks, and 16 weeks:

  • IGF-1: Primary marker for GH axis response. Target range: 200-300 ng/mL
  • Fasting glucose and HbA1c: GH can affect insulin sensitivity
  • Fasting insulin: Monitor for insulin resistance
  • Complete metabolic panel: Overall health check
  • Thyroid panel: GH can affect T4 to T3 conversion

Safety Notes

  • CJC-1295 and Ipamorelin are among the best-tolerated peptides available. Side effects are uncommon and typically mild.
  • Possible side effects include: water retention (usually resolves in 1-2 weeks), tingling or numbness in extremities, mild hunger (more common with Ipamorelin), and vivid dreams.
  • Do not use if you have active cancer or a history of cancer — GH promotes cell proliferation.
  • Individuals with diabetes should monitor blood glucose closely, as GH can affect insulin sensitivity.
  • Store reconstituted vials in the refrigerator and use within 30 days.
  • Do not mix CJC-1295 with DAC and without DAC in the same protocol.

Medical Disclaimer

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any new treatment or protocol. Read our full medical disclaimer.